MyD118 and Gadd45 are two related genes which encode for proteins that play important roles in negative growth control, including both growth suppression and apoptosis. A strategy was employed to clone new members of the MyD118 and Gadd45 family of genes. Based on alignment of the deduced amino acid sequences, one cDNA clone was found to encode for the murine homologue of human CR6, originally cloned as an IL-2 immediate-early response gene. The murine and human CR6 proteins were observed to be 97% identical, indicating that CR6 is an evolutionarily conserved protein. Analysis of CR6 expression during hematopoietic cell development associated with growth arrest and apoptotic cell death, upon exposure of hematopoietic cells to a variety of growth arrest and apoptotic stimuli, and in a variety of murine tissues, has revealed that CR6 expression diers signi®cantly from the expression of the related MyD118 and Gadd45 genes. Nevertheless, CR6, like MyD118 and Gadd45, suppressed colony formation of human lung carcinoma H1299 cells. These data suggest that CR6 plays similar, but not identical, roles to MyD118 and Gadd45 in negative control of cell growth.
Introduction
Towards dissecting the regulation of terminal differentiation associated with growth arrest and apoptosis, cDNA clones of myeloid dierentiation primary response (MyD) genes, activated in M1 myeloblastic leukemia cells in the absence of de novo protein synthesis, have been isolated and characterized Homan, 1994b, 1995) . These genes encode for ICAM-1, a ligand to a cell surface adhesion receptor, the terminal dierentiation histone variants H3.3 and H1 0 , and a variety of transcription factors, including c-jun, junB, junD, IRF-1 and EGR-1 (Lord et al., 1990b) . In the course of these studies, several novel MyD genes were isolated, including MyD118 .
Subsequent studies have shown that MyD118 is also a primary response gene to TGF-b, which induces M1 cells for growth arrest and apoptosis uncoupled from dierentiation. Using genetically engineered M1 cell lines expressing elevated levels of antisense (AS) MyD118 transcripts, has shown that blocking the early expression of MyD118 delayed TGF-b induced apoptosis, but did not aect growth arrest. It was observed that blocking TGF-b induced apoptosis in M1 cells by ectopic expression of bcl-2, down regulated MyD118 transcripts. In contrast, deregulated expression of c-myc or c-myb in M1, which abrogated TGFb-induced growth arrest and accelerated apoptosis, markedly elevated the level of MyD118 transcripts. Taken together, these ®ndings have demonstrated that MyD118 is a positive modulator of TGF-b-induced apoptosis (Selvakumaran et al., 1994b) .
It has been shown that the MyD118 encoded protein is remarkably similar to the protein encoded by Gadd45, a growth arrest and DNA damage induced gene, regulated in part by the p53 tumor suppressor (Fornace et al., 1992; Fornace, 1992) . MyD118 and Gadd45 encoded for proteins that were found to share 57% identity at the amino acid level . Furthermore, they both appeared to be negative regulators of cell growth. In M1 cells, MyD118 and Gadd45 were found to be induced by IL-6 ± a physiological inducer of M1 terminal dierentiation. They also were induced in M1 cells by the alkylating agent methyl methanesulfonate (MMS), which caused growth arrest and apoptosis. Ectopic expression of MyD118 or Gadd45 in several human tumor cell lines was found to reduce colony yields . MyD118, Gadd45 and the cyclin dependent kinase inhibitor p21 WAF1/CIP1 (a p53 target gene as well) were observed to synergize in the suppression of NIH3T3 colony formation as well (Vairapandi et al., 1996) . Additional studies have shown that both Gadd45 and MyD118 are nuclear proteins that interact with PCNA, as well as with the cyclin dependent kinase inhibitor p21 (Vairapandi et al., 1996; Kearsey et al., 1995; Smith et al., 1994) . PCNA, p21, cyclins and CDKs are normal components of multiple quaternary complexes, which play a central role in cell cycle regulation (Zhang et al., 1993; Sherr, 1994; Grana and Reddy, 1995) . Taken together, these ®ndings indicate that MyD118 and Gadd45 constitute a gene family, whose proteins interact with other cell cycle regulatory proteins and play important role(s) in negative growth control.
Here we report the cloning and characterization of a third member of the MyD118/Gadd45 gene family. The cDNA clone encoding for this third member of the MyD118/Gadd45 family is shown to be the murine homologue of human CR6, originally identi®ed as an immediate early response gene in T cells stimulated by interleukin-2 (Beadling et al., 1993) . It is shown that CR6 expression patterns diered signi®cantly from the expression of MyD118 and Gadd45 during blood cell development, in response to DNA-damage and apoptotic stimuli, and in a variety of murine tissues. Using short term transient transfection assays, also it is shown that CR6, like MyD118 and Gadd45, suppressed colony formation of human lung carcinoma H1299 cells, consistent with a role for CR6 in negative growth control. 
Results

Cloning and sequence determination of MyD118 related cDNA clones
In order to identify genes which encode for proteins related to MyD118 and Gadd45, the MyD118 cDNA fragment encoding for amino acids 37 ± 92, was chosen as a probe because it is about 80% homologous to murine Gadd45 cDNA (unpublished) (Figure 1c ). This probe was used, under low stringency hybridization conditions (Materials and methods), to screen a cDNA library prepared from RNA of M1 murine myeloid leukemia cells treated with dierentiation factors.
The 3' and 5' ends of cDNA inserts from 25 positive clones were sequenced. Twenty-three cDNA clones turned out to be MyD118. Two clones, designated as clone 74 and clone 98, were found to be distinct from MyD118 and contained overlapping parts of the same cDNA. Determination of the nucleotide sequence of clone 98 has revealed an open reading frame encoding for a polypeptide 159 amino acids in length ( Figure  1a ). There is 67% homology between the nucleotide sequence of the open reading frame of clone 98 and MyD118 (data not shown). Alignment of the amino acid sequence of clone 98 with the amino acid sequence of MyD118 showed 75% similarity (55% identity) between the encoded proteins ( Figure 1b) . Similarly, the protein sequence of clone 98 had 75% similarity (59% identity) with that of Gadd45 (Figure 1c) .
It has been reported that a sequence fragment of CR6, a human cDNA clone, isolated as an interleukin-2-induced immediate-early gene in T cells, showed 65% homology at the DNA level and 40% identity to the amino acid sequences of MyD118 and Gadd45 (Beadling et al., 1993) . Data to this account have not been published. Comparison of the nucleic acid sequence and the amino acid sequence encoded by clone 98 to the hereby published sequences of human CR6 revealed 85% homology at the nucleic acid level (data not shown) and 97% identity at the amino-acid level (Figure 1d ), thereby identifying clone 98 as a cDNA clone encoding for murine CR6 (muCR6). Alignment of the amino acid sequences of murine MyD118, Gadd45 and CR6 has revealed about 40% identity among all of these proteins, with several amino acid domains identical in all three proteins (Figure 1e, boxed) .
The protein encoded by CR6 was observed to have a mass of approximately 18 kDa, as demonstrated by in vitro translation (Figure 1f) , which is compatible with the size predicted from the amino acid sequence of CR6.
To determine the cellular localization of CR6, COS-7 cells were transiently transfected with pcDNA3.1 plasmid encoding for HA tagged CR6. pcDNA3 encoding for HA tagged p21 WAF1/CIP1 was used as a control. Antibodies against the HA tag were used to determine the cellular distribution of encoded proteins, and the proteins were visualized using secondarȳ uorenscein-conjugated anti-mouse antibody (Materials and methods). As shown in Figure 2 , CR6 protein was observed to localize both to the nucleus and cytoplasm of COS-7 cells; note CR6 perinuclear membrane staining. Cellular localization of MyD118 and Gadd45 was similar to what is shown for CR6 (data not shown). In contrast, under the same experimental conditions, p21 WAF1/CIP1 was observed to localize to the nucleus only (Figure 2 and El-Deiry et al., 1994) .
Distinct expression patterns of CR6, MyD118 and Gadd45 during hematopoietic cell development
To further characterize CR6, we analysed its expression compared to the expression of MyD118 and Gadd45 during distinct developmental programs of hematopoietic cell proliferation and dierentiation. The murine M1 myeloid leukemic cell line proliferates autonomously, in the absence of hematokines, and can be induced with the physiological hematokines interleukin-6 (IL-6), leukemia inhibitory factor (LIF), or conditioned media of mouse lungs (LUCM, containing both IL-6 and LIF) to undergo terminal macrophage dierentiation and growth arrest, which culminates in programmed cell death Selvakumaran et al., 1993) . Thus, the analysis of the developmental program of terminal hematopoietic dierentiation can be segregated from hematokine induced cell proliferation (Liebermann and Homan, 1994a,b) . As shown in Figure 3a , expression of CR6 mRNA, as well as MyD118 and Gadd45 mRNAs, was undetectable in proliferating M1 myeloblasts. Following stimulation of M1 for terminal macrophage dierentiation by IL-6, CR6 mRNA expression was detected within 1 h, approaching maximal level by 2 days, a point in time when the majority of the cells (68%) displayed an intermediate macrophage morphology, and declined by 3 days, when the majority of the Figure 2 Cellular localization of CR6. COS-7 cells were transiently transfected with HACR6pcDNA3.1 and CR6 protein was visualized with monoclonal anti-HA antibody, followed bȳ uorescein-conjugated anti-mouse antibody. HAp21pcDNA3 was used as a control. Note, perinuclear membrane localization of CR6 CR6 a third member of MyD118/Gadd45 gene famliy W Zhang et al cells (74%) displayed a mature macrophage morphology ( Figure 3a ). Like MyD118, CR6 mRNA was induced in the presence of the protein synthesis inhibitor CHX (Figure 3a ), indicating that CR6 was a myeloid dierentiation primary response (MyD) gene. In sharp contrast to the expression kinetics of Figure 3 Expression of CR6, MyD118 and Gadd45 during the developmental programs of hematopoietic cell proliferation and dierentiation. (a) Murine M1 myeloid leukemic cells were treated with IL-6 (100 ng/ml), cycloheximide (CHX) (10 mg/ml) or IL6 plus cycloheximide. (b) 32Dc13 cells were treated with G-CSF (10 ng/ml). (c) Bone marrow cells were treated with IL-3 (10% WEHI-3B conditioned medium used as source of IL-3) or GM-CSF (10 ng/ml). Total RNA was collected at the indicated time points after each treatment, RNA blots were prepared, and hybridized with murine CR6 cDNA probe, murine MyD118 probe or hamster Gadd45 probe respectively. b-actin was used as a loading and hybridization control. Relative mRNA levels were determined with the aid of a Fuji BAS 2000 phosphoimager analyzer. Mature cells and DNA synthesis were determined as indicated in Materials and methods. The values for percentage mature cells represent the mean of at least three independent determinations, with standard deviations up to +15%. Results for DNA synthesis are presented schematically as percentage of Max CR6 a third member of MyD118/Gadd45 gene famliy W Zhang et al CR6, MyD118 mRNA was maximally induced within 1 h and declined thereafter, whereas Gadd45 mRNA was detected only by 2 days with maximal expression by 3 days, when the majority of the M1 cells have ceased to proliferate and dierentiated into mature macrophages. Taken together, these ®ndings indicate that, although CR6, MyD118 and Gadd45 are related, each displayed distinct expression patterns during the developmental program of terminal hematopoietic dierentiation. Unlike M1, 32Dc13 is a hematopoietic progenitor cell line that requires interleukin-3 (IL-3) for growth and upon removal of IL-3 and addition of granulocyte colony-stimulating factor (G-CSF), is induced for proliferation and terminal granulocytic dierentiation which culminates in programmed cell death. As shown in Figure 3b , CR6, MyD118 and Gadd45 transcripts were expressed at low levels in the presence of IL-3 (zero time point). Following removal of IL-3 and addition of G-CSF, CR6 mRNA exhibited biphasic expression kinetics (Figure 3b ). CR6 mRNA expression was ®rst transiently induced to relatively low levels at early times during the proliferative phase of G-CSF stimulated 32Dc13 cells, reaching peak levels by 18 h; second, CR6 expression increased in the dierentiative phase, with high levels of expression by 7 days -a point in time when the 32Dc13 cells ceased to proliferate, with more than half of the cells (67%) exhibiting a mature granulocyte morphology, and prior to the point in time (9 days) when the mature cells underwent apoptotic cell death (Figure 3b and Krishnaraju et al., 1995) . Biphasic patterns of expression were observed also for MyD118 and Gadd45. MyD118 mRNA was transiently induced to high levels by 18 h following treatment of 32Dc13 cells with G-CSF, with a second lower peak in expression by 7 days. Gadd45 mRNA was transiently induced to relatively high levels by 18 h, followed by a second similar peak by 7 days.
Next, expression of CR6 was analysed in myeloid enriched bone-marrow cells isolated from the femurs of sodium caseinate injected mice (Materials and methods), following in vitro incubation for 6 h in the absence of hematokines (zero time point), and at dierent times of stimulation with IL-3 or GM-CSF (Figure 3c ). Both IL-3 and GM-CSF induce proliferation and dierentiation of the myeloid enriched bonemarrow cells into mature macrophages and granulocytes. IL-3 was observed to elicit a strong proliferative response, where by 6 days only a small percentage of the cells ceased to proliferate and matured ( Figure 3c and Liebermann and Homan, 1989) ; in contrast, GM-CSF induced a more limited proliferative response with the majority of the cells (67%) ceasing to proliferate and terminally dierentiating into mature granulocytes and macrophages by 6 days (Figure 3c ). Following stimulation of myeloid enriched bone-marrow cells with IL-3, expression of CR6, MyD118, and Gadd45 was rapidly up regulated by 1 h, and was maintained at about the same level for 6 days ( Figure 3c ). In contrast, upon stimulation with GM-CSF, expression of CR6, MyD118 and Gadd45 was biphasic, reminiscent of their expression patterns in the 32Dc13 progenitor cells. As shown in Figure 3c , CR6, MyD118 and Gadd45 were transiently induced by 1 h at the beginning of the proliferative phase, declined by 1 day, and reached maximal levels of expression by 6 days ± a point in time when the majority of the cells (67%) displayed a mature granulocyte or macrophage morphology.
Taken together, these ®ndings indicate that expression of CR6, MyD118 and Gadd45 is distinctly regulated during hematopoietic cell development, depending on the hematokine(s) that was used, the state of lineage commitment for proliferation and/or dierentiation, and the particular developmental program that was induced.
CR6, MyD118 and Gadd45 expression in distinct growth arrest and apoptotic pathways
The results of the experiments presented, thus far, have provided evidence that the genes of the CR6, MyD118 and Gadd45 family are dierentially regulated during the developmental program of terminal dierentiation associated with growth arrest and apoptosis. To gain further insights into the possible roles CR6 may play, we examined its expression in distinct growth arrest and apoptotic pathways which are uncoupled from dierentiation and are either independent or dependent on p53 function.
We have previously shown that M1 cells can be induced for growth arrest and apoptosis, uncoupled from dierentiation, by TGF-b (Selvakumaran et al., 1994b) and the potent genotoxic alkylating agent methyl methanesulfonate (MMS) . Since M1 cells do not express p53, these growth arrest and apoptotic pathways are p53 independent. Treatment of M1 cells with TGF-b resulted in growth arrest with 65% apoptotic cells by 2 days (Selvakumaran et al., 1994b) . As shown in Figure 4 , neither CR6 nor Gadd45 was induced in M1 cells treated with TGF-b, whereas MyD118 was rapidly induced within 1 h. Treatment of M1 cells with MMS induced growth arrest and apoptosis with 90% of the cells apoptotic by 2 days (Vairapandi et al., 1996) . Whereas expression of both MyD118 and Gadd45 was induced within 6 h, MMS did not induce CR6.
Activation of wt p53 function in M1p53(val) cell lines, expressing a temperature sensitive mutant p53 transgene (p53 ts ), was found to result in rapid apoptosis Figure 4 Expression of CR6, MyD118 and Gadd45 in response to distinct growth arrest and apoptotic stimuli. M1 cells were treated with TGF-b (10 ng/ml) or MMS (100 mg/ml). Mlp53 cells were shifted from 378C to 32.58C for activation of wt p53 function. RNA was isolated from M1 and M1p53 cells following indicated treatments at the indicated time points and subjected to RNA blot analysis Selvakumaran et al., 1994a) . As shown in Figure 4 , neither expression of CR6 nor MyD118 was induced following activation of wt p53 function, which induced expression of Gadd45.
In conclusion, the results presented in this section of the work, together with what has been shown above, further highlight the unique pattern of CR6 expression compared to the expression of MyD118 and Gadd45.
The serum response of CR6, MyD118 and Gadd45 in mouse 3T3 ®broblasts Interestingly, the results shown, thus far, provide ®rst evidence that expression of CR6, MyD118 and Gadd45 is subject to regulation both during the proliferative and dierentiative phases of blood cell development. Clearly, it was of interest to examine whether expression of these genes may also be regulated in non-hematopoietic cell types upon stimulation for proliferation. Towards this end, the expression of CR6, MyD118 and Gadd45 was analysed in quiescent BALB/c 3T3 ®broblasts that had been serum stimulated. As shown in Figure 5 , following serum starvation of the cells for 48 h and stimulation with serum, the level of CR6 mRNA was transiently increased within 30 min, reaching maximal expression by 2 h, and declining by 4 h. Also the levels of MyD118 and Gadd45 mRNAs were observed to be transiently increased following stimulation of the BALB/c 3T3 cells with serum. Like several other immediate early serum response genes in BALB/c 3T3 cells, such as c-fos and c-myc (Lau and Nathans, 1987) , CR6 expression, as well as MyD118 and Gadd45, was superinduced in the presence of serum and CHX. Similar results were obtained using serum stimulated NIH3T3 ®broblasts (data not shown).
Distinct expression of CR6, MyD118 and Gadd45 in murine tissues
Expression of CR6, MyD118 and Gadd45 was also analysed in a variety of murine tissues (Figure 6 ). Highest expression of CR6 mRNA was detected in skeletal muscle. Expression of CR6 also was high in kidney and liver, whereas relatively low expression levels were observed in heart, brain, spleen, lung, and testis. In contrast, highest expression of MyD118 mRNA was detected in lung tissue. MyD118 expression was lower in skeletal muscle and liver, and low in kidney, spleen, brain, heart and testis. Dierent patterns of expression were observed for Gadd45. It was high in kidney and skeletal muscle, lower in spleen, heart, lung, brain and liver, and low in testis.
Taken together, these ®ndings demonstrate that expression of CR6, MyD118 and Gadd45 vary to a large extent in murine tissues, with each gene displaying an unique pattern of expression.
CR6 suppresses colony formation of human tumor cells
Previously, using short term transfection assays, it was demonstrated that MyD118 and Gadd45 suppress colony formation of several human tumor cell lines, including H1299 lung carcinoma cells , thereby providing direct evidence for the growth inhibitory functions of these proteins. Thus, towards better understanding the role of CR6, it was of interest to examine the eect of CR6 on the cologenicity of H1299 cells, using a short term transfection assay. To do so, expression vectors containing CR6, MyD118, Gadd45 or p53 cDNAs were co-transfected with the plasmid pTK-hygro, providing the selectable marker, into exponentially growing H1299 cells. Hygromycin resistant colonies were scored after 2 weeks. As shown in Table 1 and Figure 7 , transfection of H1299 cells with vector encoding for CR6 reduced colony yields by about 70%, compared to cells transfected with empty vector, or vector encoding for antisense CR6 (data not shown). In the same experiment, MyD118 and Gadd45 exhibited similar inhibition of H1299 colony formation, whereas p53 had a more pronounced eect, consistent with previously published data Vairapandi et al., 1996) . Similar results were obtained with NIH3T3 cells (data not shown).
Taken together, these ®ndings indicate that CR6, like MyD118 and Gadd45, has negative growth control functions.
Discussion
In search for new genes related to MyD118 and Gadd45, we have cloned the murine homolog of human CR6 ± originally identi®ed as an IL-2 immediate-early response gene in T cells (Beadling et al., 1993) . Alignment of the amino acid sequence of murine CR6 with the sequence of human CR6 showed 97% identity, indicating that CR6 is a highly conserved protein. CR6 represents the third known member in the MyD118/Gadd45 family of genes. These three genes encode for evolutionarily conserved proteins that are about 40% identical and harbor several conserved domains whose biological significance remains to be determined. The CR6 encoded protein is similar in size (159aa) to the MyD118 (160aa) and Gadd45 (165aa) proteins. It has been shown that MyD118 and Gadd45 are acidic proteins which have an unusually high net negative charge . According to the formula [1006 (K+R-D-E)/total residues], MyD118 has a negative charge per cent of 711.3 and Gadd45 has a negative charge per cent of 79.1. Such high acidity is not common in most proteins. In the case of CR6, it has a negative charge per cent of 712.6. The similar structure and charge characteristics suggest similar functions for these proteins.
Analysis of the expression of CR6 in several model systems of hematopoietic cell development has shown that the expression patterns of CR6 diered from the expression of MyD118 and Gadd45 during blood cell development. CR6 expression also diered from the expression of MyD118 and Gadd45 upon exposure of M1 hematopoietic cells to a variety of growth arrest and apoptotic stimuli. Finally the expression of CR6 diered from the expression of the related MyD118 and Gadd45 genes in a variety of murine tissues. Nevertheless, CR6, like MyD118 and Gadd45, was found to inhibit colony formation of human H1299 and murine NIH3T3 cells. Whether the ability of CR6 to inhibit H1299 and NIH3T3 colony formation is due to growth inhibition, decrease in cell survival, or both of these phenomena, is being investigated taking advantage of vectors where expression of CR6 is under control of an inducible promoter. Similar vectors are being used to investigate the role of CR6, as well as MyD118 and Gadd45, in terminal dierentiation, including growth arrest and apoptosis, of hematopoietic cells. Whether CR6, MyD118 and Gadd45 can synergize in the inhibition of colony formation, as previously reported for MyD118 and Gadd45 Vairapandi et al., 1996) , is also being explored.
Unlike MyD118 and Gadd45, CR6 expression was not induced in M1 cells by TGF-b, p53 or MMS, which induced M1 apoptosis. Thus, experiments are underway to determine how these agents, as well as other growth arrest and apoptotic stimuli (i.e. IL-1, IFN-g, TNF, UV, g-irradiation) may eect CR6 expression in a panel of dierent cell types, including cells of hematopoietic and non-hematopoietic origins.
Interestingly, expression of CR6, as well as MyD118 and Gadd45, was observed to be transiently induced during the proliferative phase of blood cell development, as well as upon serum stimulation of quiescent ®broblasts. The signi®cance of these observations Figure 7 Suppression of human H1299 lung carcinoma colony formation by CR6. Human H1299 cells were transfected with 10 mg of expression vectors without insert or with indicated inserts and pTK-hygro as in Table 1 . After 14 days, hygromycinresistant colonies were scored As shown for empty vector, neither transfection with pcDNA3 vectors encoding for antisense CR6, MyD118 or Gadd45, nor transfection with pcDNA3 encoding for bactin, reduced colony formation remains to be determined. It is noteworthy, in this context, that the expression of other growth suppressive genes, i.e. p21, was similarly observed to be transiently induced upon serum stimulation of cells (Zeng and El-Deiry, 1996) . It has been suggested that the transient increase in p21 upon serum stimulation of ML1 cells may re¯ect a role for p21 in regulating G1/S re-entry. Whether this may be the case for CR6, MyD118, and/or Gadd45 remains to be seen.
From what has been shown in this work, it is clear that the expression of CR6 diers from the expression of MyD118 and Gadd45 under a variety of conditions. These observations combined with the ability of CR6 to inhibit H1299 and NIH3T3 colony formation indicate that CR6 may play similar, but not identical, roles to MyD118 and Gadd45 in negative growth control. The results of ongoing work will be instrumental to further delineate the growth arrest and apoptotic stimuli, as well as the cell types, where the functions of CR6 may be similar or dierent from those of MyD118 and Gadd45.
CR6 protein, like MyD118 and Gadd45 proteins, were found to localize to both the nucleus and cytoplasm of transiently transfected COS-7 cells. Intriguingly, all of these proteins were observed to display a distinct pattern of perinuclear membrane localization ( Figure 7 ). Recently we have reported that MyD118, like Gadd45 (Smith et al., 1994) , is a nuclear protein that interacts with the DNA replication and repair protein PCNA and the cyclin dependent kinase inhibitor p21 WAF1/CIP1 (Vairapandi et al., 1996) . MyD118 and Gadd45 also were found to stimulate DNA repair in vitro (Vairapandi et al., 1996) . Whether CR6 may interact with PCNA, P21, and may stimulate DNA repair remains to be determined. Pursuing the biological consequence of such interactions should shed light on the mechanisms by which this family of small acidic proteins function in negative growth control.
Upon completion of this work, another group of investigators has described a family of stress-inducible Gadd45-like proteins that mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK (Takekawa and Saito, 1998) . These Gadd45-like proteins appear to include the human homolog of murine MyD118 and human CR6. MTK1/MEKK4 mediates activation of the p38 and JNK MAPK pathways in response to environmental stresses, such as DNA damage agents, and anti-mitogenic cytokines (Ip and Davis, 1998; Holbrook et al., 1996) . These observations, thus, further highlight the important roles played by proteins of the MyD118/Gadd45/CR6 family in negative growth control, and raise new intriguing questions as to their mechanism of action.
Materials and methods
Cell culture and cell treatment
The dierentiation competent murine M1 myeloid leukemia cell line and the M1p53 cell line were described before (Selvakumaran et al., 1994a) and cultured in Dulbecco's Modi®ed Eagles medium (DMEM, GIBCO) supplemented with 10% horse serum (GIBCO). The dierentiation competent 32Dc13 cells were described previously (Krishnaraju et al., 1995) and cultured in RPMI 1640 (GIBCO) supplemented with 10% fetal bovine serum (FBS, Sigma) and 10% WEHI-3B conditioned medium (source of IL-3).
BALB/c 3T3, NIH3T3, COS-7 and H1299 cells were obtained from ATCC and cultured in DMEM plus 10% FBS. Myeloid enriched bone marrow cells used for in vitro studies were obtained from CD-1 female mice (4 ± 6 weeksold) injected with 10% sodium casinate 3 days earlier in order to increase the myeloid population in the bone marrow cells. The bone marrow cells were¯ushed from femurs of the above mice with phosphate-buered saline (PBS) containing 2% FBS and subsequently resuspended in DMEM containing 10% FBS after erythrocytes among the bone marrow cells were lyzed with 0.17 M NH 4 Cl. Puri®ed human rIL-6 (Amgen Inc.) was used at a concentration of 100 ng/ml. Puri®ed recombinant G-CSF (Amgen Inc.) and GM-CSF (Amgen Inc.) was used at a concentration of 10 ng/ml. Porcine TGFb (R&D systems) was used at a concentration of 10 ng/ml. MMS was used at a concentration of 100 mg/ml. Cycloheximide was used at a concentration of 10 mg/ml. Serum starvation experiments were performed using the procedures of Lau and Nathans (1987) .
Assays for dierentiation and DNA synthesis
Morphological dierentiation was determined by counting at least 300 cells on May-Grunwald-Giemsa stained cytospin smears, and scoring the proportion of immature blast cells, cells at intermediate granulocyte or monocyte stage of dierentiation, and mature granulocytes or macrophages (Nguyen et al., 1993) . DNA synthesis was determined by incorporation of [ 3 H]thymidine into TCA precipitable material as previously described .
cDNA cloning and sequencing
Uni-ZAP XR custom cDNA library was prepared from M1 murine myeloid leukemia cells treated with LUCM and CHX (Stratagene). A radiolabeled MyD118 cDNA fragment corresponding to amino acid residues 37 ± 92 of MyD118 protein was used to screen this library under low stringency hybridization conditions. Hybridization was performed in 56SSC (16SSC is NaCl plus 0.015 M sodium citrate), 0.1% sodium dodecyl sulfate (SDS), Denhardt's solution, 30% formamide, 100 mg/ml of salmon sperm DNA at 428C for 14 h. Filters were washed in 26SSC, 0.1% SDS at 378C twice for 30 min and then in 16SSC, 0.1% SDS at 378C twice for 30 min. Positive clones were identi®ed after three rounds of screening and plaque puri®cation. pBluescript phagemides were excised from positive Uni-ZAP clones using ExAssist helper phage. cDNA inserts were sequenced by dideoxy nucleotide termination method using sequenase Version 2.0 (Amersham Life Science Inc.) according to manufacturers' speci®cations. Both strands of clone 98 were sequenced. DNA and the amino acid homologies were determined by the GCG program (University of Wisconsin Genetics Computer Group package).
In vitro translation
Coupled in vitro transcription and translation of murine CR6 cDNA was carried out using Promega's TNT Coupled Wheat Germ Extract System. The pBluescript vector (Clone 98) containing murine CR6 cDNA was linearized with KpnI. Wheat germ extract translation was performed using RNA synthesized from T3 RNA polymerase promoters according to the supplier's protocols. In vitro translated Met-35 S-labeled protein was run on a 15% denaturing SDS-polyacrylamide gel, vacuum dried and autoradiographed.
Immunochemistry
The coding region of CR6 from pAS2.1 vector was cloned into HApcDNA3.1, kindly provided by Dr Dhanasekaran.
HA tagged coding region of p21 from pACT2 vector was cloned into BamHI site of pcDNA3. COS-7 cells were seeded on sterile glass cover slips, transiently transfected with HAp21 or HACR6, ®xed with methanol (7108C) for 5 min, washed with PBS. Nonspeci®c staining was blocked by incubating the cells with 10% horse serum in PBS. After incubation with 5 mg/ml monoclonal HA antibody (BabCO) in PBS plus 3% BSA for 3 h, the proteins were visualized, using secondary¯uorenscein-conjugated anti-mouse antibody (GIBCO ± BRL), under a¯uorenscence microscope.
Northern blot analysis
RNA was extracted using TRIzol reagent (GIBCO ± BRL). Total RNA (10 mg per lane) was electrophoresed on 1% agarose formaldehyde gels, blotted onto Duralon-UV membranes agarose (Stratagene) and covalently bound by UV cross-linking. Membranes were hybridized with dierent probes overnight at 428C, in 50% deionized formamide, 10% dextran sulfate, 1 M NaCl, 1% Sodium dodecyl sulfate (SDS), and 100 mg/ml of salmon sperm DNA. Blots were washed at room temperature in 26SSC, 0.1% SDS for 5 min twice, at 608C in 0.16SSC, 1% SDS for 30 min twice, and exposed to the X-ray ®lm at 7808C for 12 ± 48 h. Mouse multiple tissue Northern blots were purchased from Clontech, Inc. (Palo Alto, CA, USA), hybridized and washed according to manufacturers' instructions. Stripping of the blots, to rehybridize with other probes, was performed as previously described (Lord et al., 1990a) . The probes used are a KpnI ± EcoRI fragment of the mouse CR6 cDNA, a XbaI ± SpecI fragment of the hamster Gadd45 (90% homologous to mouse Gadd45) and a BamHI ± EcoRI fragment of the mouse MyD118 cDNA, excised from pBluescript vectors. All probes were a 32 P-labeled by random priming (RadPrime DNA labeling: GIBCO/BRL).
Colony formation assay
The ApaI-NotI fragment of pBluescript, encoding for full length CR6 was blunt-end cloned into the unique NotI site of pcDNA3. Both sense and anti-sense constructs were obtained. The BglII fragments of pACT2, encoding for HA tagged coding region of Gadd45 and MyD118 were cloned into the unique BamHI site of pcDNA3 (Vairapandi et al., unpublished) . pCMV-p53 is a gift from Dr Bert Vogelstein. pTK-hyg was obtained from Clontech, Inc.. All plasmids were puri®ed by CsCl gradients. H1299 lung carcinoma cells were plated at a density of 2610 5 cells/dish in 60 mm tissue culture dishes the day before the transfection. Ten mg of appropriate constructs and 0.5 mg of pTK-hyg, as selectable marker, were added to the cells in serum free DMEM, combined with 8 ml/dish lipofectamine Reagent (GIBCO/ BRL) according to the procedure suggested by the supplier. Cells were incubated in the presence of the DNAlipofectamine mixture for 8 h and then refed with DMEM and 10% FBS. After 48 h of transfection, 200 mg/ml hygromycin was added. Cells were refed every 6 days, ®xed and stained with Crystal Violet (Sigma) after 14 days, and scored for colonies containing more than 30 cells.
